Canaan Inc ADRCAN
Price$0.34

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $529.7M+96.7% YoYTTM through 31 Dec 2025
Net Income -$210.3MTTM through 31 Dec 2025
Free Cash Flow -$295.8MTTM through 31 Dec 2025

Margins

Current
Gross Margin-36.5%
EBITDA Margin-21.1%
Operating Margin-86.6%
Net Margin-39.7%

Returns

-55.7%ROE
-40.0%ROA

Balance Sheet Health

Debt / Equity0.14x
Current Ratio3.31x
Net Debt$11.1M
Cash & Equivalents$80.8M

Quality Metrics

Altman Z-Score0.42
Piotroski F-Score5 / 9
FCF Margin-55.8%
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $529.7M
Diluted EPS-$2.99TTM
'19'20'21'22'23'24'25
FY2025: $-0.03

Dividend

No dividend

Capital Allocation

R&D Spend$63.1M
Capex Intensity4.6%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.